Clinical Trial Update: BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for IvoneScimab in combination with a Trop2-targeted antibody-drug conjugate for brain metastases in patients with triple-negative…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Triple-negative Breast Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)
• Trop2 ADC

Snippet

Sponsor: Fudan University | Conditions: Triple-Negative Breast Cancer (TNBC), Brain Metastases | Phase 2 | Status: RECRUITING